Liting Liu

发表

Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission.

R. Sun, H. Mai, Qiu-Yan Chen, 2022, Oral oncology.

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy

Jiangtao Liang, H. Mai, Qiu-Yan Chen, 2021, BMC cancer.

EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Huanliang Liu, 2022, Cell Death & Differentiation.

Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.

Rui Sun, Lu Zhang, Xiang Guo, 2016, Journal of the National Cancer Institute.

Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT

R. Sun, Xiaofei Lv, H. Mai, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [18F]‐fluorodeoxyglucose positron emission tomography

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Cancer medicine.

Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort Study

R. Sun, C. Qian, M. Zeng, 2018, Journal of Cancer.

Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study

H. Mai, Qiu-Yan Chen, Chao-chao Du, 2022, European Radiology.

Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Frontiers in Oncology.

The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma.

Ying Sun, Jun Ma, J. Shao, 2015, International journal of radiation oncology, biology, physics.

Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis.

R. Liu, J. Bei, C. Qian, 2019, Cancer letters.

Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2022, BMC cancer.

First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study

H. Mai, Qiu-Yan Chen, Sailan Liu, 2022, Cancer control : journal of the Moffitt Cancer Center.

M1 stage subdivisions based on 18F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma

H. Mai, Huan-xin Lin, Ling Guo, 2022, Therapeutic advances in medical oncology.

Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Annals of translational medicine.

Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

Ying Sun, Jun Ma, J. Shao, 2018, BMC Cancer.

Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma.

Ying Sun, Jun Ma, H. Mai, 2019, European journal of cancer.

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.

Ying Huang, R. Sun, C. Qian, 2018, The Lancet. Oncology.

Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection

H. Mai, Qiu-Yan Chen, Lin-Quan Tang, 2022, BMC Cancer.

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma

M. Chua, Y. Tao, H. Mai, 2019, Cancer communications.

Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis

Jun Ma, J. Bei, Chong Zhao, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study

H. Mai, Qiu-Yan Chen, Chao-chao Du, 2022, Advances in radiation oncology.

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer communications.

The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, Journal of Cancer.

Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study

H. Mai, Qiu-Yan Chen, Chao-chao Du, 2022, European Radiology.

Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection

H. Mai, Xiang Guo, Qiu-Yan Chen, 2020, Cancer biology & medicine.

Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy

Ying Sun, Jun Ma, J. Shao, 2015, Oncotarget.

Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysis

Ying Sun, Jun Ma, J. Shao, 2016, Oncotarget.

The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, International journal of radiation oncology, biology, physics.

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Prognostic Value of Plasma Epstein–Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era

D. Xie, C. Qian, M. Zeng, 2016, Medicine.

The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients

Ying Sun, Jun Ma, J. Shao, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Oral oncology.

Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?

C. Qian, M. Zeng, Xiang Guo, 2015, PloS one.

Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort Study

Jun Ma, H. Mai, M. Hong, 2019, Cancer research and treatment : official journal of Korean Cancer Association.

Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (≥2 lines) anti-programmed death-1 monotherapy.

H. Mai, Sailan Liu, Liting Liu, 2023, Oral oncology.

Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I–II nasopharyngeal carcinoma: a nest case-control study

R. Sun, Xiaofei Lv, H. Mai, 2021, European Radiology.

Optimizing the Treatment Pattern for De Novo Metastatic Nasopharyngeal Carcinoma Patients: A Large-Scale Retrospective Cohort Study

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Frontiers in Oncology.

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, BMC Cancer.

Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Frontiers in Pharmacology.

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy

Xiang Guo, H. Mai, M. Hong, 2014, Radiation oncology.

Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial

R. Sun, Qing Liu, Chong Zhao, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of Transnasal Endoscopic Fine‐Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma

H. Mai, Qiu-Yan Chen, Dong-Xiang Wen, 2021, The Laryngoscope.

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Qingmei He, Na Liu, Jun Ma, 2018, Cancer communications.

Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Pei-yu Huang, 2016, Oncotarget.

Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score–matched analysis

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Elevated High-Sensitivity C-Reactive Protein Levels Predict Decreased Survival for Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era

C. Qian, L. Tang, M. Zeng, 2015, PloS one.

Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study

R. Sun, C. Qian, Xiang Guo, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020

H. Mai, Qiu-Yan Chen, Yujing Liang, 2022, JAMA network open.

Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.

Jun Ma, J. Shao, J. Bei, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study

R. Sun, C. Qian, M. Zeng, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma

Li-Zhi Liu, Hai-xia Deng, D. Xie, 2014, BMC Cancer.

The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, International journal of radiation oncology, biology, physics.

Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?

H. Mai, Qiu-Yan Chen, Liting Liu, 2021, Oral oncology.

The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy

Ying Sun, Jun Ma, J. Shao, 2015, BMC Cancer.

Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.

Ying Sun, Jun Ma, J. Shao, 2017, Radiology.

Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, European journal of cancer.

Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, BMC Cancer.

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study

Ying Sun, Jun Ma, J. Shao, 2016, Oncotarget.

Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma

D. Xie, C. Qian, M. Zeng, 2015, Oncotarget.

Different Prognostic Values of Plasma Epstein-Barr Virus DNA and Maximal Standardized Uptake Value of 18F-FDG PET/CT for Nasopharyngeal Carcinoma Patients with Recurrence

C. Qian, M. Zeng, Xiang Guo, 2015, PloS one.

High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study.

Y. Zeng, C. Qian, M. Zeng, 2015, International journal of radiation oncology, biology, physics.

Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma

R. Sun, H. Mai, H. Mo, 2021, JAMA network open.

Establishment of an integrated model for predicting survival and guiding treatment in local recurrence nasopharyngeal carcinoma

R. Sun, H. Mai, Qiu-Yan Chen, 2020 .

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study

Ying Sun, Jun Ma, J. Shao, 2017, BMC Cancer.

With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case–control study

Ying Sun, Jun Ma, J. Shao, 2016, BMC Cancer.

Establishment of a prognostic nomogram to identify optimal candidates for local treatment among patients with local recurrent nasopharyngeal carcinoma.

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Oral oncology.

Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma

H. Mai, H. Mo, Qiu-Yan Chen, 2020, Therapeutic advances in medical oncology.

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level

H. Mai, Qiu-Yan Chen, Yujing Liang, 2020, BMC Cancer.

Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinoma.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, Oral oncology.

The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer management and research.

The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019 .

Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus DNA

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Head & neck.

Subdivision of de novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment Epstein-Barr virus DNA for therapeutic guidance of primary tumor radiotherapy

Jiangtao Liang, H. Mai, Qiu-Yan Chen, 2021 .

Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer research and treatment : official journal of Korean Cancer Association.

The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis

Xiao-Dan Lin, H. Mai, Qiu-Yan Chen, 2019, Journal of Cancer.

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer medicine.

Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study

H. Mai, Qiu-Yan Chen, Zhen-Chong Yang, 2022, Head & neck.

Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

Ying Sun, Jun Ma, J. Shao, 2018, BMC Cancer.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, BMC Cancer.

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.

Ying Huang, R. Sun, Chong Zhao, 2023, The Lancet. Oncology.

Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients

R. Sun, H. Mai, H. Mo, 2020, Frontiers in Oncology.

A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients.

Jiang Li, R. Sun, J. Xia, 2023, European journal of cancer.

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein–Barr virus DNA level after induction chemotherapy

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Aging.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Management of first‐line palliative chemotherapy for post‐treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non‐gemcitabine plus cisplatin chemotherapy

H. Mai, Qiu-Yan Chen, Chao-chao Du, 2021, Head & neck.

Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [18F]FDG PET/CT parameters

H. Mai, Qiu-Yan Chen, Yujing Liang, 2022, European Radiology.

MiR-663, a microRNA targeting p21WAF1/CIP1, promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma

J. Yun, X. Zhou, Lei Wang, 2012, Oncogene.

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Xiaofei Lv, M. Zeng, H. Mai, 2023, Nature communications.

Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma

Chuan-miao Xie, R. Sun, H. Mai, 2021, BMC Cancer.

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study

Ying Sun, Jun Ma, J. Shao, 2017, BMC Cancer.

Xiang Guo, H. Mai, Qiu-Yan Chen, 2015, Oncotarget.

Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.

R. Sun, Chong Zhao, H. Mai, 2023, European journal of cancer.

Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study

D. Dong, Lianzhen Zhong, H. Mai, 2023, BMC Medicine.

Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA–IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial

Wan-Ping Guo, H. Mai, H. Mo, 2023, The Lancet regional health. Western Pacific.

Management of Suboptimal Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Re-induction Therapy or Direct to Radiotherapy?

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer medicine.

High Extracellular Matrix Stiffness Promotes the Metastasis of Nasopharyngeal Carcinoma through STAT3/FGF1 Positive Feedback Regulation Activated by JAK2

H. Mai, Qiu-Yan Chen, D. Luo, 2024, Precision Medicine and Engineering.

Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial

L. Ke, W. Xia, Chong Zhao, 2024, Nature communications.

Ying Huang, R. Sun, Chong Zhao, 2023, The Lancet. Oncology.